abstract |
The present invention provides and discloses a polymorphic form I (S) -2- (1- (9H-purin-6-ylamino) propyl) -5-fluoro-3-phenylquinazolin-4 (3H) -one, containing the indicated form of the composition, methods for the preparation and use of this form. |